# NAD+ research guide NAD+ is a coenzyme - a small helper molecule every living cell needs to run its chemistry. It is not a peptide and not an approved medicine. This guide walks through what the research actually says about it, and what it does not. Form Labs materials are research reference materials, not the approved medicines; no Form Labs product is approved for human or veterinary use. - Identity: CAS 53-84-9, molecular formula C21H27N7O14P2, molecular weight 663.43 g/mol (Form Labs catalogue record). - Sirtuin link: a laboratory experiment showed the yeast enzyme Sir2 only worked when NAD+ was present (Imai et al., Nature, 2000). - Precursors: most human work in this field used NMN and NR rather than NAD+ itself (Covarrubias et al., Nature Reviews Molecular Cell Biology, 2021). - The supplied material remains laboratory research material. Matching current certification is unverified; historical sample reports do not verify current lot identity, purity or release status. 3: Literature context: three NAD+-using enzyme groups are named here - sirtuins, PARPs, and CD38. This count is not a product result. (NAD+ enzyme-family literature context: https://doi.org/10.1016/j.tibs.2006.11.006) 3: Literature context: three NAD+-using enzyme groups are named here - sirtuins, PARPs, and CD38. This count is not a product result. (NAD+ enzyme-family literature context: https://doi.org/10.1016/j.tibs.2006.11.006) 2: Identity context: NAD+ and NADH are the paired redox forms named in the guide. This is chemistry context, not a product result. (NAD+ and NADH redox-pair identity: https://doi.org/10.1038/s41580-020-00313-x) ## Why is NAD+ studied? NAD+ is studied because it is a coenzyme, a small helper molecule every living cell needs to run its chemistry. This guide describes NAD+ as not a peptide. Researchers study NAD+ for its role in electron-transfer chemistry as part of the NAD+/NADH pair, and for the sirtuin, PARP and CD38 enzyme families that use NAD+ up. NAD+ literature and laboratory findings. Research use only means this material is sold for in-vitro laboratory work - controlled experiments outside a living body. It is not tested, packaged or approved as a medicine, supplement or food, and it must not be used in or on people or animals. Belenky et al. (Trends in Biochemical Sciences, 2007) reviewed NAD+ synthesis, recycling and consumption in published cell-biology experiments. Imai et al. (Nature, 2000) reported NAD+-dependent Sir2 activity in purified yeast protein and cell extracts, with no animals or people. The source guide keeps study context separate from Form Labs product claims. ## What laboratory observations have NAD+ studies reported? Imai et al. (Nature, 2000) reported that purified yeast Sir2 required NAD+ for histone deacetylation and consumed NAD+ during the reaction. The NAD+ experiment involved purified protein and yeast cell extracts, with no animals or people. Covarrubias et al. (Nature Reviews Molecular Cell Biology, 2021) reviewed the broader literature; precursor findings remain separate from NAD+ findings. NAD+ laboratory findings ### Redox literature Belenky et al. (Trends in Biochemical Sciences, 2007) reviewed NAD+ synthesis, recycling and consumption in published cell-biology experiments. ### Sir2 laboratory experiment Imai et al. (Nature, 2000) reported NAD+-dependent Sir2 activity in purified yeast protein and cell extracts, with no animals or people. ### Precursor distinction Covarrubias et al. (Nature Reviews Molecular Cell Biology, 2021) reviewed predominantly animal intervention evidence and distinguished NMN and NR from NAD+ itself. | | | | --- | --- | | Research code | NAD+ | | Class | NAD+ identity, redox-pair chemistry, and NAD+-using enzyme literature. Class wording here means the research category named by the source guide. | | Molecule | NAD+ / nicotinamide adenine dinucleotide; identity wording comes from the source guide and matching product record. | | Reported half-life | Not listed in the source guide for this consumer entry; half-life means the time for a measured amount to fall by half. | | Originator | Not listed in the source guide; Form Labs did not run the cited studies. | | Approval status | Laboratory research material only. | ## What has NAD+ been studied for? NAD+ research covers three study areas: NAD+ redox chemistry and enzyme-substrate biology, the sirtuin co-substrate record in which Sir2 and sirtuin enzymes use NAD+ as a co-substrate, and NAD+ pathway reviews across metabolism, DNA repair, chromatin, senescence and immune-cell literature. All three are literature topics, not product results. ### NAD+ redox and enzyme-substrate biology Study topic: how NAD+ sits in redox chemistry and in enzyme systems that consume it. Belenky et al., Trends Biochem Sci, 2007 ### Sirtuin co-substrate record Study topic: Sir2 and sirtuin enzymes using NAD+ as a co-substrate during deacetylase reactions. Imai et al., Nature, 2000 ### NAD+ pathway overview Study topic: cellular pathways where NAD+ is discussed across metabolism, DNA repair, chromatin, senescence, and immune-cell literature. Covarrubias et al., Nat Rev Mol Cell Biol, 2021 ## Published studies ## What did the NAD+ studies find? The three NAD+ studies cited in this guide are two reviews and one laboratory experiment. Belenky et al. (Trends in Biochemical Sciences, 2007) surveyed how cells make, recycle and spend NAD+. Imai et al. (Nature, 2000) showed the sirtuin enzyme Sir2 only worked when NAD+ was present, in purified yeast protein with no animals or people. Covarrubias et al. (Nature Reviews Molecular Cell Biology, 2021) reviewed the wider NAD+ pathway literature. ### NAD+ redox and enzyme-substrate overview Belenky et al., Trends Biochem Sci, 2007. Review article - it gathers and summarises other researchers' experiments rather than reporting a new one. A survey of how cells make NAD+, how they recycle it, and which enzymes use it up. | | | | --- | --- | | Studied in | Published cell-biology literature spanning yeast, bacterial and mammalian cell studies. | | Design | The authors read the existing experimental literature on NAD+ and organised it into the routes cells use to build the molecule and the routes that consume it. | | Measured | Nothing new was measured here. The value of the paper is the map it draws: which reactions produce NAD+, and which spend it. | Cells do not make NAD+ once and keep it (Belenky et al., Trends Biochem Sci, 2007). They run a constant recycling loop, because enzymes such as sirtuins, PARPs and CD38 break NAD+ apart when they act (Belenky et al., Trends Biochem Sci, 2007). That is why the same molecule turns up in papers on energy metabolism and in papers on DNA repair - it is being spent in both places (Belenky et al., Trends Biochem Sci, 2007). https://doi.org/10.1016/j.tibs.2006.11.006 ### Sir2/sirtuin NAD+ co-substrate paper Imai et al., Nature, 2000. Laboratory experiment using purified proteins and yeast cell extracts. No animals and no people. The experiment that showed the sirtuin enzyme Sir2 cannot do its job without NAD+. | | | | --- | --- | | Studied in | Purified yeast Sir2 protein and yeast cell extracts, in vitro. | | Design | The researchers gave the Sir2 enzyme its target and watched whether it acted - once with NAD+ present, once with NAD+ absent. | | Measured | Whether Sir2 stripped acetyl groups from histones, the spool proteins DNA winds around, and whether NAD+ was consumed while it did so. | Sir2 only worked when NAD+ was present, and it used the NAD+ up as it went (Imai et al., Nature, 2000). That tied a gene-regulating enzyme directly to the cell's energy chemistry: how much NAD+ is around becomes a signal the enzyme can read (Imai et al., Nature, 2000). Most later research linking NAD+ to ageing traces back to this connection (Imai et al., Nature, 2000). https://doi.org/10.1038/35001622 ### Cellular NAD+ pathway review Covarrubias et al., Nat Rev Mol Cell Biol, 2021. Review article - a stocktake of the field written two decades after the sirtuin work, not a new experiment. A survey of where NAD+ research had reached, and of how much of the evidence comes from animals rather than people. | | | | --- | --- | | Studied in | Published literature spanning cell culture, mouse studies, and a smaller number of human trials. | | Design | The authors reviewed the accumulated research on NAD+ across metabolism, DNA repair, cell ageing and immune signalling. | | Measured | No new measurement. The review's contribution is stating plainly which claims rest on mouse data and which have human evidence behind them. | NAD+ levels were reported to fall with age in several tissues, while the enzymes that consume NAD+ grow busier at the same time (Covarrubias et al., Nat Rev Mol Cell Biol, 2021). The review is careful about what that does and does not establish: most of the intervention evidence comes from animals, and from the precursors NMN and NR rather than NAD+ itself, so the human picture remained open (Covarrubias et al., Nat Rev Mol Cell Biol, 2021). https://doi.org/10.1038/s41580-020-00313-x ## What does the NAD+ research mean, and what does it not? The NAD+ guide is a literature map, not a product claim. Most intervention evidence comes from animals and from the precursors NMN and NR rather than NAD+ itself (Covarrubias et al., Nature Reviews Molecular Cell Biology, 2021), so findings about those precursors should not be read as findings about NAD+. Where the source guide does not list participant counts or study details, this page does not invent them. ### The source guide is a literature map, not a product claim The cited papers are used for identity, pathway, marker, model, or analytical context. They do not become Form Labs results or promises. ### Study details are limited to the source record Where the source guide does not list participant counts, model details, study amounts, or study-stage labels, this page does not invent them. ### Label and available report Storage and batch decisions should follow the product label and any verified matching COA. Source storage note: 2-8 C, dry and protected from light. ## How is NAD+ handled as reference material? NAD+ is laboratory reference material, not for human consumption or veterinary use. Storage and lot checks follow the product label and any verified matching certificate of analysis (COA). This guide's catalogue record notes storage at 2-8 C and protection from light. Historical sample reports do not verify current lot identity, purity or release status. ### Research-use boundary Follow the product label and laboratory procedures for storage. Historical sample reports do not establish current lot identity, purity or release status. ### Educational boundary This guide summarises third-party literature; Form Labs did not run the cited studies. ### Research-use boundary For laboratory research use only. 21+ only. Not for human consumption or veterinary use. ## Plain-English definitions. ### NAD+ Nicotinamide adenine dinucleotide; a coenzyme named in redox and enzyme-substrate papers. ### NADH The paired reduced form that cycles with NAD+ in redox chemistry. ### Electron transfer Movement of electrons from one molecule to another during a chemical reaction. ### Coenzyme A small molecule that helps enzymes carry out chemical reactions. ### Sirtuin An NAD+-dependent enzyme-family name in papers on protein deacetylation and cell signalling. ### PARP Poly(ADP-ribose) polymerase; an enzyme-family name in DNA-repair literature. ### CD38 A cell-surface enzyme named in immune-cell signalling and NAD+-consuming enzyme literature. ### COA Certificate of analysis; the batch paperwork that controls identity, purity, appearance, and release checks. ### Research use only A lab-only boundary. It means not for human consumption, veterinary use, medical use, or cosmetic use. ### Literature context A plain summary of what cited papers discuss, not a product result. ## What are the most common questions about NAD+? NAD+ is described in this guide as a coenzyme, not a peptide. The most common questions about NAD+ cover the difference between NAD+ and NADH, how NAD+ differs from NMN and NR, which enzymes use up NAD+, whether NAD+ declines with age, what the Sir2 experiment showed and its Australian status. Form Labs supplies NAD+ as laboratory reference material only. ### What is NAD+? NAD+ is a coenzyme - a small helper molecule every living cell needs to run its chemistry. It is not a peptide, and it is not an approved medicine. Form Labs supplies it strictly as laboratory reference material. ### What is the difference between NAD+ and NADH? NAD+ and NADH are the same molecule in two states: NAD+ before it takes electrons on, NADH after. The cell cycles it back and forth all day, which is why papers write the pair as NAD+/NADH rather than treating them as two separate things. ### Is NAD+ the same as NMN or NR? No. NMN and NR are precursors - molecules the body converts into NAD+. This distinction matters when reading the literature: most human work in this field used those precursors rather than NAD+ itself, so a finding about NMN or NR should not be read as a finding about NAD+. ### Which enzymes use up NAD+? Three enzyme families consume NAD+ outright rather than borrowing it: sirtuins, PARPs and CD38. PARPs are called in when DNA is damaged; sirtuins are studied around how genes get switched on and off. Because these families consume it, researchers describe NAD+ as something the cell has to keep replacing. ### Does NAD+ decline with age? Reviews report NAD+ levels falling with age in several tissues while the enzymes that consume it grow busier at the same time. The review authors are careful about what that establishes: most of the intervention evidence comes from animals, and from the precursors NMN and NR rather than NAD+ itself. The human picture remains open. ### What did the Sir2 experiment show? Sir2 only worked when NAD+ was present, and used the NAD+ up as it went - tying a gene-regulating enzyme directly to the cell's energy chemistry. That was a laboratory experiment on purified yeast protein: no animals and no people. ### Is NAD+ an approved medicine in Australia? No. NAD+ is not an approved medicine and is not on the Australian Register of Therapeutic Goods. Form Labs supplies it as laboratory reference material only, not for human or veterinary use. ## References - Plain note: NAD+ redox and enzyme-substrate overview. Citation: Belenky et al., Trends Biochem Sci, 2007.. DOI means a permanent article link code; DOI: 10.1016/j.tibs.2006.11.006. DOI: 10.1016/j.tibs.2006.11.006 - Plain note: Sir2/sirtuin NAD+ co-substrate paper. Citation: Imai et al., Nature, 2000.. DOI means a permanent article link code; DOI: 10.1038/35001622. DOI: 10.1038/35001622 - Plain note: Cellular NAD+ pathway review. Citation: Covarrubias et al., Nat Rev Mol Cell Biol, 2021.. DOI means a permanent article link code; DOI: 10.1038/s41580-020-00313-x. DOI: 10.1038/s41580-020-00313-x ![One box labelled Coenzyme joined by lines to boxes labelled Sirtuins, PARPs and CD38; CD38 is an enzyme within the NADase class described by Covarrubias et al. (2021).](/assets/content/ra-coenzyme-three-enzyme-families.png) Covarrubias et al. (Nature Reviews Molecular Cell Biology, 2021) describe NAD+ as a coenzyme and sirtuins, PARPs and NADases as NAD+-consuming enzyme classes, with CD38 within the NADase class. The diagram names sirtuins, PARPs and CD38 as examples; these are cell-chemistry topics in the literature. --- Canonical page: https://www.formlaboratories.com/research/nad-plus Form Laboratories - Perth-based research-use-only peptide supplier, shipping Australia-wide. - Site guide for agents: https://www.formlaboratories.com/llms.txt - Sitemap: https://www.formlaboratories.com/sitemap.xml - Full catalogue: https://www.formlaboratories.com/shop - Contact: hello@formlaboratories.com All materials are supplied for laboratory research use only - not for human or veterinary use, and nothing on this site is medical advice.